Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction: prevalence and clinical data.
about
Gene expression profiling reveals stromal genes expressed in common between Barrett's esophagus and adenocarcinomaBOB CAT: A Large-Scale Review and Delphi Consensus for Management of Barrett's Esophagus With No Dysplasia, Indefinite for, or Low-Grade Dysplasia.Monitoring the premalignant potential of Barrett's oesophagus'.A segregation analysis of Barrett's esophagus and associated adenocarcinomas.Normalization of intestinal metaplasia in the esophagus and esophagogastric junction: incidence and clinical data.Assessment of familiality, obesity, and other risk factors for early age of cancer diagnosis in adenocarcinomas of the esophagus and gastroesophageal junction.Cell cycle regulation in patients with intestinal metaplasia at the gastro-oesophageal junction.The diagnosis of dysplasia and malignancy in Barrett's oesophagus.Meta-analyses of the effect of symptoms of gastroesophageal reflux on the risk of Barrett's esophagus.A cross-sectional analysis of the prevalence of Barrett esophagus in otolaryngology patients with laryngeal symptoms.Burden of gastrointestinal disease in the United States: 2012 update.Barrett's oesophagus: epidemiology, cancer risk and implications for management.British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus.Diagnosis and management of Barrett's esophagus for the endoscopist.Epidemiology of gastroesophageal reflux disease in Asia: a systematic reviewSurveillance in Barrett's oesophagus: a personal viewThe miR-106b-25 polycistron, activated by genomic amplification, functions as an oncogene by suppressing p21 and BimSmoking and Barrett's esophagus in women who undergo upper endoscopy.Impact of laparoscopic Nissen fundoplication on non-complicated Barrett's esophagusPhotodynamic therapy for esophageal cancer: a useful and realistic option.Adherence to biopsy guidelines for Barrett's esophagus surveillance in the community setting in the United States.Epidemiology and natural history of intestinal metaplasia of the gastroesophageal junction and Barrett's esophagus: a population-based study.The Impact of Uncertainty in Barrett's Esophagus Progression Rates on Hypothetical Screening and Treatment Decisions.Inflammation of the gastro-oesophageal junction (carditis) in patients with symptomatic gastro-oesophageal reflux disease: a prospective studyPatterns of gastritis in patients with gastro-oesophageal reflux diseaseRelative risk of dysplasia for patients with intestinal metaplasia in the distal oesophagus and in the gastric cardia.Utility of endoscopy for diagnosis of barrett in a non-Western society: endoscopic and histopathologic correlation.The gastric cardia in gastro-oesophageal diseaseInflammation and cytokeratin 7/20 staining of cardiac mucosa in young patients with and without Helicobacter pylori infectionHuman defensin 5 expression in intestinal metaplasia of the upper gastrointestinal tract.Studies of acid exposure immediately above the gastro-oesophageal squamocolumnar junction: evidence of short segment reflux.Inflammation and intestinal metaplasia at the squamocolumnar junction in young patients with or without Helicobacter pylori infection.A substantial incidence of silent short segment endoscopically suspected esophageal metaplasia in an adult Japanese primary care practice.Hereditary gastrointestinal cancer syndromes.Biomarkers in the molecular pathogenesis of esophageal (Barrett) adenocarcinoma.Cigarette smoking increases risk of Barrett's esophagus: an analysis of the Barrett's and Esophageal Adenocarcinoma Consortium.Improvement over time in outcomes for patients undergoing endoscopic therapy for Barrett's oesophagus-related neoplasia: 6-year experience from the first 500 patients treated in the UK patient registryThe association between Barrett's esophagus and Helicobacter pylori infection: a meta-analysis.Barrett's Esophagus: Emerging Knowledge and Management StrategiesThe interplay between Helicobacter pylori, gastro-oesophageal reflux disease, and intestinal metaplasia.
P2860
Q24646856-8D03A768-82CF-4F2D-BD2B-996EF5184474Q27332349-87AF2FFC-BF1B-4A1B-8378-182E0FCEF9D8Q28080195-7166FDEC-298B-41BD-B95F-55E9EA3C1128Q30493653-29B8051A-16D9-4B78-888E-74F5B7EE262CQ31083667-EA4DE4A2-6C0E-4EA3-B149-CF351FE207AEQ33828452-E8C1877A-A98F-49D6-BA07-5CD66E611D7DQ33919260-4D1FF818-0101-450F-A787-1B19826D3100Q33994505-B3BD2C03-0EE9-4A5F-9726-087A5E894D12Q34047762-8D3FD427-6826-4098-B3CF-36E99255C54EQ34217680-AB271CCB-6308-40F5-AF80-EC83C45CA2CCQ34293512-17E237AF-6785-46EB-AFDE-D281902BF7B6Q34375216-F793FF93-C374-4882-B0FC-F44D99C4FBDEQ34380645-F178923D-4DFB-4792-BACD-60A88F2E3AECQ34409192-C9FA8624-6802-4335-A84E-A66ED0E74F47Q34588743-2663802A-F7FD-4C22-B2A8-648F812C0E48Q34769005-9300C1E4-293A-4888-AB42-C5529F58B579Q34979616-A351D1B8-F125-4CDE-A124-99CBDF65EC5AQ35000990-140E1B99-4FB6-4E4F-A4EF-5F33F411EE64Q35064918-A3D7CF5F-8FD8-455C-AA6E-1493FE980795Q35081101-8C15E5CD-DF1D-44FA-ADE3-35D98EA362CAQ35114043-F55E97DF-A437-44D4-8AF2-6216129EDEF9Q35147677-9DDC2F46-90EC-45D7-9827-2203EECEF4F1Q35252139-E0DA8BBD-B05F-4C2B-8725-4378BF813AC2Q35357359-E177A569-F94E-4660-A343-06A82B9726F6Q35357928-A11A0922-C48C-4F89-9B27-E576596A9961Q35358348-586CFCE1-D8C6-466C-A48D-57D1ED4625A0Q35457196-4A155515-9AFF-4BA3-B9D4-A23C6EBCBAB3Q35570968-17E01EDB-B720-4242-BCE8-775C2B50B88CQ35588464-A68138CF-B9C3-4397-AFF2-D0D0E6F2677CQ35588688-F5561E4D-09B2-48B4-8D9F-09BBC283666DQ35598291-E577B960-FD64-41D8-918B-F5025058A5B1Q35598364-82127519-1ADF-47D3-BB78-6AB832E04512Q35759506-8440DE4F-6FE1-4318-917E-FE4D591400E9Q35767560-091C2FDA-3346-4A0B-B7FC-158B50E712DCQ35840327-D5114FF4-69E8-46B3-9D4F-3A0E11E49382Q35874758-1E642414-556C-40A6-850F-4AEB041B5045Q35891829-5DF1E450-048E-486D-83AF-C04CAB677BC9Q35910796-13EC2022-02AC-466B-8311-472F504B94BDQ36014649-62D1703D-DCA7-4260-90B7-9C6360F751CCQ36041651-B9589319-4909-4B97-A516-7866C742FEFC
P2860
Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction: prevalence and clinical data.
description
1999 nî lūn-bûn
@nan
1999 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Specialized intestinal metapla ...... prevalence and clinical data.
@ast
Specialized intestinal metapla ...... prevalence and clinical data.
@en
type
label
Specialized intestinal metapla ...... prevalence and clinical data.
@ast
Specialized intestinal metapla ...... prevalence and clinical data.
@en
prefLabel
Specialized intestinal metapla ...... prevalence and clinical data.
@ast
Specialized intestinal metapla ...... prevalence and clinical data.
@en
P2093
P1433
P1476
Specialized intestinal metapla ...... prevalence and clinical data.
@en
P2093
P304
P356
10.1016/S0016-5085(99)70123-X
P407
P577
1999-02-01T00:00:00Z